Xarelto Bleeding Lawsuits Could Head to Trial Next Summer

Published on July 1, 2015 by Sandy Liebhard

Text-Size:A A A+


The federal court overseeing hundreds of Xarelto lawsuits could begin sending cases to trial in August 2016. According to court documents, a bellwether trial program was the subject of discussion during a status conference convened last month in the U.S. District Court, Eastern District of Louisiana, where all federally-filed Xarelto injury claims have been consolidated for the purposes of coordinated pretrial proceedings.

50 Xarelto Lawsuits to Be Chosen for Initial Trial Pool

The minutes from that meeting indicate that the Court has proposed creating an initial pool of 50 potential bellwether cases, all of which would be subjected to case-specific discovery. The first two Xarelto trials would begin on August 1, 2016 and August 22, 2016, and each would take place in the Eastern District of Louisiana. The third would be convened on September 12, 2016 in the Southern District of Texas, and the fourth on October 17, 2016 in the Southern District of Mississippi.

Bellwether trials are an important part of any federal multidistrict litigation. The cases chosen for trial are intended to be representative of other lawsuits pending in the proceeding. It is hoped that the outcomes of such rulings will provide insight into the way juries might rule in similar Xarelto lawsuits.

Court documents indicate that more than 500 Xarelto lawsuits are currently pending in the Eastern District of Louisiana, all of which were filed on behalf of individuals who suffered uncontrollable internal bleeding and other serious complications allegedly related to its use. The litigation was established in December 2014, in the expectation that hundreds of similar cases would be filed in federal courts around the country.

All of the Xarelto claims pending in the federal multidistrict litigation similarly accuse the drug’s manufacturers of wrongly positioning the medication as a superior alternative to warfarin. Among other things, they point out that internal bleeding associated with this much older blood thinner can be stopped via the administration of vitamin K. By contrast, there exists no approved remedy to reverse Xarelto bleeding side effects.

Discuss Your Xarelto Claim with an Attorney Today

If you or a loved one took Xarelto and experienced uncontrollable internal bleeding, stroke, deep vein thrombosis, or pulmonary embolism, it’s important that you discuss your legal rights with an attorney as soon as possible. To arrange for a free case review with Bernstein Liebhard LLP, please call today.

Web Analytics